John Blenis

68.5k citations
226 papers · 52.8k · 32 hit papers · h-index 102

Impact in

  • Aging top 0.1%
    • PI3K/AKT/mTOR signaling in cancer
    • Protein Kinase Regulation and GTPase Signaling
    • Melanoma and MAPK Pathways
    • Metabolism, Diabetes, and Cancer
    • Cell death mechanisms and regulation
    • Ubiquitin and proteasome pathways
    • FOXO transcription factor regulation

Papers in

    • PI3K/AKT/mTOR signaling in cancer 70
    • Protein Kinase Regulation and GTPase Signaling 63
    • Melanoma and MAPK Pathways 34
    • Ubiquitin and proteasome pathways 15
    • Polyamine Metabolism and Applications 15
    • Cell death mechanisms and regulation 15

John Blenis

221 papers receiving 52.1k citations

John Blenis's Hit Papers

Rapamycin: One Drug, Many Effects 2014 · 964 citations
9640+7+15Years since publication50010001.5k2.0k

Peers

John Blenis
Comparison fields: 5 of 163
  • Aging 1.2k
  • Molecular Biology 38.0k
  • Cancer Research 5.2k
  • Cell Biology 6.1k
  • Immunology 6.3k
Replace Hediye Erdjument‐Bromage with:
Hediye Erdjument‐Bromage United States
Dario R. Alessi United Kingdom
Paul Tempst United States
Keiji Tanaka Japan
Pier Giuseppe Pelicci Italy
Richard J. Youle United States
Junying Yuan United States
Johannes L. Bos Netherlands
Michael N. Hall Switzerland
J. Wade Harper United States
John Blenis relative to Hediye Erdjument‐Bromage United States Hediye Erdjument‐Bromage's profile →
Citations per field
00.5×1.6×
Hediye Erdjument‐Bromage · 1×
Citations per year

Countries citing papers authored by John Blenis

Since Specialization
Citations

This map shows the geographic impact of John Blenis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Blenis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Blenis more than expected).

Fields of papers citing papers by John Blenis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Blenis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Blenis. The network helps show where John Blenis may publish in the future.

Co-authors

The 25 scholars most cited alongside John Blenis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Blenis Line = papers co-authored together John Blenis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 226 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Hit paper breakdown →
19995474
2
Molecular mechanisms of mTOR-mediated translational control
Hit paper breakdown →
20092014
3
ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions
Hit paper breakdown →
20041988
4
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Hit paper breakdown →
20111382
5
Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway
Hit paper breakdown →
20021287
6
Signal transduction via the MAP kinases: proceed at your own RSK.
Hit paper breakdown →
19931128
7
Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
Hit paper breakdown →
19921039
8
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
Hit paper breakdown →
20041030
9
Nuclear localization and regulation of erk- and rsk-encoded protein kinases.
Hit paper breakdown →
1992968
10
mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events
Hit paper breakdown →
2005967
11
Rapamycin: One Drug, Many Effects
Hit paper breakdown →
2014964
12
Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb
Hit paper breakdown →
2003954
13
Phosphatidylinositol 3-Kinase Activation Is Required for Insulin Stimulation of pp70 S6 Kinase, DNA Synthesis, and Glucose Transporter Translocation
Hit paper breakdown →
1994912
14
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Hit paper breakdown →
2002878
15
ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK
Hit paper breakdown →
1992842
16
Molecular interpretation of ERK signal duration by immediate early gene products
Hit paper breakdown →
2002766
17
mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E
Hit paper breakdown →
2003734
18
FADD/MORT1 and Caspase-8 Are Recruited to TRAIL Receptors 1 and 2 and Are Essential for Apoptosis Mediated by TRAIL Receptor 2
Hit paper breakdown →
2000677
19
Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling
Hit paper breakdown →
2011676
20
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
Hit paper breakdown →
2008652

About John Blenis

John Blenis is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Immunology, having authored 226 papers that have together received 52.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (70 papers), Protein Kinase Regulation and GTPase Signaling (63 papers), Melanoma and MAPK Pathways (34 papers), Tuberous Sclerosis Complex Research (17 papers), Cancer, Hypoxia, and Metabolism (16 papers), Ubiquitin and proteasome pathways (15 papers), Polyamine Metabolism and Applications (15 papers) and Cell death mechanisms and regulation (15 papers). The work is most often cited by research in Aging (1.2k citations), Molecular Biology (38.0k citations), Cancer Research (5.2k citations), Cell Biology (6.1k citations) and Immunology (6.3k citations). John Blenis has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Philippe P. Roux, Diane C. Fingar, Xiaoju Max, Andrew R. Tee, Peter Juo, Rey‐Huei Chen, Lewis C. Cantley, Leon O. Murphy, Bryan A. Ballif and Calvin J. Kuo. Their work appears in journals such as Molecular and Cellular Biology, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Molecular Cell and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact